1.WJ G, BO A, R B, SL B, HJ B, A C, AD E, WB F, A F, SH G: Breast cancer version 2.2015. Journal of the National Comprehensive Cancer Network Jnccn 2015, 13(4):448–475.
2.Scorilas A, Karameris A, Arnogiannaki N, Ardavanis A, Bassilopoulos P, Trangas T, Talieri M: Overexpression of matrix-metalloproteinase–9 in human breast cancer: a potential favourable indicator in node-negative patients. British Journal of Cancer 2001, 84(11):1488.
3.Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J: Cancer statistics in China, 2015. Ca Cancer J Clin 2016, 66(2):115–132.
4.Hirotsu Y, Nakagomi H, Sakamoto I, Amemiya K, Oyama T, Mochizuki H, Omata M: Multigene panel analysis identified germline mutations of DNA repair genes in breast and ovarian cancer. Molecular genetics & genomic medicine 2015, 3(5):459–466.
5.Dai Z-J, Liu X-H, Ma Y-F, Kang H-F, Jin T-B, Dai Z-M, Guan H-T, Wang M, Liu K, Dai C: Association between single nucleotide polymorphisms in DNA polymerase kappa gene and breast cancer risk in Chinese Han population: a STROBE-compliant observational study. Medicine 2016, 95(2).
6.Ren H-T, Li Y-M, Wang X-J, Kang H-F, Jin T-B, Ma X-B, Liu X-H, Wang M, Liu K, Xu P: PD–1 rs2227982 polymorphism is associated with the decreased risk of breast cancer in northwest Chinese women: a hospital-based observational study. Medicine 2016, 95(21).
7.Horowitz K, McGuire WL: Predicting response to endocrine therapy in human breast cancer: a hypothesis. Science 1975, 189(4204):726–727.
8.Jensen EV, Jordan VC: The estrogen receptor: a model for molecular medicine. Clinical Cancer Research 2003, 9(6):1980–1989.
9.Lapidus RG, Nass SJ, Davidson NE: The loss of estrogen and progesterone receptor gene expression in human breast cancer. Journal of mammary gland biology and neoplasia 1998, 3(1):85–94.
10.Javed S, Ali M, Sadia S, Aslam MA, Masood AI, Shaikh RS, Sayyed AH: Combined effect of menopause age and genotype on occurrence of breast cancer risk in Pakistani population. Maturitas 2011, 69(4):377–382.
11.Weiderpass E, Persson I, Melhus Hk, Wedrén S, Kindmark A, Baron JA: Estrogen receptor α gene polymorphisms and endometrial cancer risk. Carcinogenesis 2000, 21(4):623–627.
12.Schüler S, Lattrich C, Skrzypczak M, Fehm T, Ortmann O, Treeck O: Polymorphisms in the promoter region of ESR2 gene and susceptibility to ovarian cancer. Gene 2014, 546(2):283–287.
13.Huang Q, Wang T-h, Lu W-s, Mu P-w, Yang Y-f, Liang W-w, Li C-x, Lin G-p: Estrogen receptor alpha gene polymorphism associated with type 2 diabetes mellitus and the serum lipid concentration in Chinese women in Guangzhou. Chinese medical journal 2006, 119(21):1794–1801.
14.Binh TQ, Shinka T, Khan NC, Hien VTT, Lam NT, Nakano T, Sei M, Yamamoto S, Nakamori M, Nakahori Y: Association of estrogen receptor alpha gene polymorphisms and lifestyle factors with calcaneal quantitative ultrasound and osteoporosis in postmenopausal Vietnamese women. Journal of human genetics 2006, 51(11):1022.
15.Kuźbicka K, Rachoń D, Woziwodzka A, Rybicka M, Bielawski KP: Associations of ESR1 and ESR2 gene polymorphisms with metabolic syndrome and its components in postmenopausal women. Maturitas 2018, 115:97–102.
16.Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, Maranian M, Seal S, Ghoussaini M, Hines S, Healey CS: Genome-wide association study identifies five new breast cancer susceptibility loci. Nature genetics 2010, 42(6):504.
17.Fletcher O, Johnson N, Orr N, Hosking FJ, Gibson LJ, Walker K, Zelenika D, Gut I, Heath S, Palles C: Novel breast cancer susceptibility locus at 9q31. 2: results of a genome-wide association study. Journal of the National Cancer Institute 2011, 103(5):425–435.
18.Xia P, Jin T, Geng T, Sun T, Li X, Dang C, Kang L, Chen C, Sun J: Polymorphisms in ESR1 and FLJ43663 are associated with breast cancer risk in the Han population. Tumor Biology 2014, 35(3):2187–2190.
19.Zhou L, He N, Feng T, Geng T, Jin T, Chen C: Association of five single nucleotide polymorphisms at 6q25. 1 with breast cancer risk in northwestern China. American journal of cancer research 2015, 5(8):2467.
20.Clemons M, Goss P: Estrogen and the risk of breast cancer. New England Journal of Medicine 2001, 344(4):276–285.
21.Osborne CK, Schiff R, Fuqua SA, Shou J: Estrogen receptor: current understanding of its activation and modulation. Clinical Cancer Research 2001, 7(12):4338s–4342s.
22.Vachon CM, Van Gils CH, Sellers TA, Ghosh K, Pruthi S, Brandt KR, Pankratz VS: Mammographic density, breast cancer risk and risk prediction. Breast Cancer Research 2007, 9(6):217.
23.Orr N, Cooke R, Jones M, Fletcher O, Dudbridge F, Chilcott-Burns S, Tomczyk K, Broderick P, Houlston R, Ashworth A: Genetic variants at chromosomes 2q35, 5p12, 6q25. 1, 10q26. 13, and 16q12. 1 influence the risk of breast cancer in men. PLoS genetics 2011, 7(9):e1002290.
24.DM H, TD H, KB B, DP M, X L, GA H, DM R, J X, SL Z, DA M: Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation 2002, 105(16):1879–1882.
25.Hu X, Jiang L, Tang C, Ju Y, Jiu L, Wei Y, Guo L, Zhao Y: Association of three single nucleotide polymorphisms of ESR1 with breast cancer susceptibility: a meta-analysis. Journal of biomedical research 2017, 31(3):213.
26.Abbasi S, Nouri M, Azimi C: Estrogen receptor genes variations and breast cancer risk in Iran. International journal of clinical and experimental medicine 2012, 5(4):332.
27.Anghel A, Narita D, Seclaman E, Popovici E, Anghel M, Tamas L: Estrogen receptor alpha polymorphisms and the risk of malignancies. Pathology & Oncology Research 2010, 16(4):485–496.
28.RC S, M A, M N, N S, SC S, AM A: Genetic variants of EGFR (142285G>A) and ESR1 (2014G>A) gene polymorphisms and risk of breast cancer. Molecular and Cellular Biochemistry 2012, 369(1–2):217–225.
29.Sauna ZE, Kimchi-Sarfaty C, Ambudkar SV, Gottesman MM: Silent polymorphisms speak: how they affect pharmacogenomics and the treatment of cancer. Cancer research 2007, 67(20):9609–9612.
30.Quan L, Hong C-C, Zirpoli G, Roberts MR, Khoury T, Sucheston-Campbell LE, Bovbjerg DH, Jandorf L, Pawlish K, Ciupak G: Variants of estrogen-related genes and breast cancer risk in European and African American women. Endocrine-related cancer 2014, 21(6):853–864.
31.Wang J, Higuchi R, Modugno F, Li J, Umblas N, Lee J, Lui L-Y, Ziv E, Tice JA, Cummings SR: Estrogen receptor alpha haplotypes and breast cancer risk in older Caucasian women. Breast cancer research and treatment 2007, 106(2):273–280.